| abstract |
Compositions that include combinations of agents that inhibit carbohydrate degradation, decrease formation or severity of intestinal gas, and/or modulate insulin signalling or blood glucose levels are described. Methods of administering these compositions are also described, for example, to reduce or prevent post-prandial glucose spikes. |